Adherium & AstraZeneca Partner To Bring Class-Leading Inhaled Medications To Respiratory Disease Patients
COPD, News
New Zealand-based Adherium (NZ) Limited (formerly known as Nexus6) has entered a long term partnership with London, U.K. based multinational biopharmaceutical company AstraZeneca in what the company believes is a ... Read more